Concepedia

Radhika Bal

RB

3

Publications

199

Citations

3

H-Index

1995

Active since

Affiliations

Abbott Fund(Current)

Radhika Bal is an author at Abbott Fund specializing in natural sciences, medicinal chemistry, and drug discovery.

Top concepts

Natural SciencesMedicineBiochemistryPharmacologyDrug DiscoveryMedicinal ChemistryMolecular PharmacologyPhysicsChemistryEngineering

Publications per year

1995–1996

3

Publications

3

2,4-Diarylpyrrolidine-3-carboxylic AcidsPotent ET<sub>A</sub> Selective Endothelin Receptor Antagonists. 1. Discovery of A-127722

Martin Winn, Thomas W von Geldern, Terry J. Opgenorth et al. · Journal of Medicinal Chemistry · 1996 · 110 citations · Full text

Combinatorial Chemistry, Molecular Pharmacology, Medicinal Chemistry +12

Torsional Low-Frequency Reorganization Energy of Biphenyl Anion in Electron Transfer Reactions

John R. Miller, Basil Paulson, Radhika Bal et al. · The Journal of Physical Chemistry · 1995 · 45 citations

Engineering, Proton-coupled Electron Transfer, Altmetric Attention Score +17

Azole Endothelin Antagonists. 2. Structure−Activity Studies

Thomas W von Geldern, Jeffrey A. Kester, Radhika Bal et al. · Journal of Medicinal Chemistry · 1996 · 44 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Conformational Restriction +14

Rows per page

1–3 of 3